|
Daily Medical Update
Constipation (Chronic, secretagogues)
Monday, March 23, 2026
|
🔬 Practice‑Changing Findings
Evidence from RCTs and meta‑analyses published in the last 12 months.
|
Nutrients (2026) - Randomized Controlled Trial
Key Findings
- Weekly spontaneous complete bowel movements increased from 1.5 to 2.6 in the treatment arm, while placebo showed no comparable change (p < 0.001).
- Mean Bristol stool score improved from 1.4 to 3.5, with reductions in bloating and abdominal pain and no reported adverse events or rescue-treatment use.
📋 Practice Implication: For adults interested in non-prescription adjuncts, consider a time-limited monitored trial while continuing guideline-based baseline therapy and follow-up.
|
Gastroenterology research (2026) - Prospective Observational Study
Key Findings
- In 97 patients, symptom scores improved by weeks 2 and 4, with strongest gains in hard stool, difficult defecation, and infrequent bowel movements.
- Failure to respond by week 2 predicted poorer week-4 outcomes across patient-reported improvement, symptom intensity, and bowel movement frequency metrics.
📋 Practice Implication: Use a 2-week checkpoint in primary care to escalate or switch treatment early rather than extending ineffective regimens.
|
The American journal of clinical nutrition (2026) - Systematic Review and Network Meta-Analysis
Key Findings
- Across 19 randomized trials, fruit-based and multi-component dietary interventions increased bowel movement frequency compared with placebo and several active comparators.
- For stool consistency and constipation severity, multi-component and fruit-based interventions showed greater improvement than placebo and fiber-supplement comparators in the network analysis.
📋 Practice Implication: At treatment initiation, pair medication plans with specific food-based prescriptions (not generic advice alone) to improve early bowel outcomes.
|
|
Evidence in this run supports a practical stepped approach for chronic constipation, combining targeted pharmacologic or adjunctive options with early response checks and dietary optimization. A placebo-controlled RCT showed improved bowel frequency and stool form with sea buckthorn extract, while additional evidence highlights the value of a 2-week reassessment and food-based interventions. A multicenter probiotic RCT showed limited overall benefit, helping refine where adjunctive therapies may or may not add value.
|
|